Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2020

 With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended on 30th September, 2020. The time of commencement of the Board Meeting was 3:00 p.m. and the time of conclusion was 4:00 p.m. We request you to kindly take the same on record.
22-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Outcome Of The Board Meeting

 With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended on 30th September, 2020. The time of commencement of the Board Meeting was 3:00 p.m. and the time of conclusion was 4:00 p.m. We request you to kindly take the same on record.
22-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Final Approval for Tavaborole Topical Solution, 5%. Please find enclosed herewith our press release. We request you to kindly take the same on record.
22-10-2020
Bigul

Alembic Pharma gets USFDA nod for cholesterol lowering drug

 Drug firm Alembic Pharma on Wednesday said it has received approval from the US health regulator for Fenofibrate capsules, which reduces cholesterol
21-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
21-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 The exchange is hereby informed that the Company's Post Results Conference Call will be held on 22nd October, 2020 at 5:00 p.m., as per the revised details enclosed. We request you to kindly take the same on record.
19-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Updates: Board Meeting Intimation

 In continuation of our earlier intimation dated 9th October, 2020, we would like to inform that some Directors of the Company are abroad and hence the Board Meeting scheduled for Thursday, 22nd October, 2020 will start at 3:00 p.m. IST. Accordingly, the Outcome of the Board Meeting will be submitted to the stock exchanges after conclusion of the Board Meeting which shall be after the closure of market hours.
19-10-2020

Alembic Pharmaceuticals gets USFDA nod for anti-viral drug

 The approved product is therapeutically equivalent to the reference listed drug product Symmetrel tablets of Endo Pharmaceuticals, Inc.
16-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Amantadine Hydrochloride Tablets, 100 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
16-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the shareholder(s) or their legal heir(s) of such lost share certificate have requested the Company for issue of duplicate share certificate.
15-10-2020
Next Page
Close

Let's Open Free Demat Account